Pancreatic ductal adenocarcinoma (PDA) carries a dismal prognosis, due largely to the fact that it metastasizes early and is typically detected late, when tumors can no longer be resected. Obesity increases an individual?s risk of developing PDA, although the mechanisms driving this link are poorly understood. This proposal investigates the hypothesis that insulin signaling in PDA cells promotes metabolic alterations and changes in gene expression that facilitate tumor development and progression, potentially pointing towards new strategies to prevent PDA in at-risk populations or to improve PDA treatment outcomes. Histone acetylation is highly sensitive to the availability of the acetyl donor acetyl-CoA, and our previous work has defined a role for the metabolic enzyme ATP-citrate lyase (ACLY) in the regulation of histone acetylation levels in diverse mammalian cell types. Histone acetylation plays key roles in PDA tumorigenesis, although the mechanisms that drive altered histone acetylation are not well understood. In preliminary studies, we have found that insulin and insulin-like growth factor (IGF) stimulation of PDA cells results in ACLY Ser455 phosphorylation, increasing its activity, as well as elevated levels of global histone acetylation. ACLY is phosphorylated downstream of AKT, and AKT inhibition suppresses histone acetylation globally and at cancer- relevant loci. We hypothesize that elevated insulin/IGF levels promote metabolic and transcriptional remodeling in PDA cells, promoting tumor progression. To test this, we will define the role of insulin/IGF signaling in metabolic and epigenetic remodeling in KRAS mutant PDA cells, using a combination of hypothesis-driven and unbiased approaches. Finally, we will test the role of ACLY in mediating obesity-linked pancreatic tumorigenesis, as well as the potential to target acetyl-CoA-dependent processes to suppress tumor growth and improve therapeutic responses. This study will elucidate new mechanisms through which systemic metabolism influences cellular metabolism and the tumor epigenome. Findings from this study have potential to provide a mechanistic rationale for nutritional recommendations for PDA patients and/or to identify new therapeutic targets to prevent tumor recurrence after surgical resection or to use in conjunction with chemotherapy to improve its efficacy.
Obesity is associated with a higher risk of developing pancreatic cancer and worse disease prognosis. Although elevated levels of insulin and insulin-like growth factors contribute to tumor progression and chemotherapeutic resistance, the underlying mechanisms are poorly understood. The metabolic enzyme ATP- citrate lyase (ACLY) is activated in response to insulin signaling and regulates histone acetylation levels in cancer cells, and the proposed study will test the hypothesis that metabolic alterations mediate epigenetic and transcriptional changes to promote tumor progression and may represent targetable vulnerabilities.
|Lee, Joyce V; Berry, Corbett T; Kim, Karla et al. (2018) Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca2+-NFAT signaling. Genes Dev 32:497-511|
|Sivanand, Sharanya; Viney, Isabella; Wellen, Kathryn E (2018) Spatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation. Trends Biochem Sci 43:61-74|
|Sivanand, Sharanya; Rhoades, Seth; Jiang, Qinqin et al. (2017) Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination. Mol Cell 67:252-265.e6|
|Carrer, Alessandro; Parris, Joshua L D; Trefely, Sophie et al. (2017) Impact of a High-fat Diet on Tissue Acyl-CoA and Histone Acetylation Levels. J Biol Chem 292:3312-3322|
|Zhao, Steven; Torres, AnnMarie; Henry, Ryan A et al. (2016) ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch. Cell Rep 17:1037-1052|
|Shah, Supriya; Carriveau, Whitney J; Li, Jinyang et al. (2016) Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism. Oncotarget 7:43713-43730|
|Kinnaird, Adam; Zhao, Steven; Wellen, Kathryn E et al. (2016) Metabolic control of epigenetics in cancer. Nat Rev Cancer 16:694-707|
|Su, Xiaoyang; Wellen, Kathryn E; Rabinowitz, Joshua D (2016) Metabolic control of methylation and acetylation. Curr Opin Chem Biol 30:52-60|
|Carrer, Alessandro; Wellen, Kathryn E (2015) Metabolism and epigenetics: a link cancer cells exploit. Curr Opin Biotechnol 34:23-9|
|Aird, Katherine M; Worth, Andrew J; Snyder, Nathaniel W et al. (2015) ATM couples replication stress and metabolic reprogramming during cellular senescence. Cell Rep 11:893-901|
Showing the most recent 10 out of 11 publications